Stocks & ETFs Screener: 98 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
966B | 82.1% | 71.3% | 58.1% | 52.9 | 19.1% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Devices, Lenses |
501B | 74.2% | 60.2% | 64.6% | 20.1 | 25.3% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
287B | 86.4% | 46.0% | 45.5% | 30.8 | 4.80% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
286B | 79.5% | 40.2% | 56.4% | 30.6 | 21.7% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular, Oncology |
266B | 91.8% | 56.2% | 69.2% | 19.0 | 24.7% |
| MRK Merck |
Pharmaceuticals
Oncology Vaccines Antimicrobials |
266B | 83.0% | 62.7% | 36.6% | 14.1 | -6.74% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity, Growth, Blood |
234B | 89.3% | 34.8% | -53.4% | 14.3 | -48.4% |
| PFE Pfizer |
Pharmaceuticals
Medicines, Vaccines, Biosimilars |
142B | 57.4% | 74.6% | -12.6% | 14.6 | -14.5% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Immunology, Oncology |
118B | 61.7% | 52.2% | 10.0% | 15.8 | -10.9% |
| SAN Sanofi |
Pharmaceuticals
Vaccines, Oncology, Neurology |
116B | 75.2% | 65.3% | -16.3% | 15.6 | -21.7% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Immunotherapy |
111B | 73.3% | 76.0% | -9.55% | 18.4 | -15.0% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
99.1B | 76.9% | 14.5% | 75.1% | 13.6 | 28.5% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
98.7B | 80.1% | 28.2% | 52.0% | 13.7 | 11.2% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Filtration, Antibodies |
61.7B | 61.6% | 62.9% | -23.5% | 17.7 | -25.2% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
56.0B | 83.4% | 71.2% | -53.7% | 21.3 | -33.5% |
| TAK Takeda |
Pharmaceuticals
Oncology, Gastroenterology |
52.1B | 62.5% | 31.5% | 53.5% | 224 | 4.63% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
41.6B | 46.3% | 1.0% | 36.1% | - | 61.3% |
| TEVA Teva Pharma |
Pharmaceuticals
Generics, Respiratory, CNS |
36.6B | 53.0% | 17.8% | 65.9% | 52.3 | 20.3% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Biopharma, Investments |
22.9B | 56.4% | 61.0% | 71.0% | 22.4 | 31.9% |
| VTRS Viatris |
Pharmaceuticals
Brand, Generic, Biosimilar |
14.1B | 28.9% | 58.5% | 24.1% | - | -10.7% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.8B | 76.5% | 45.1% | -10.8% | 17.8 | -24.0% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Neuroscience, Rare |
11.6B | 87.4% | 52.4% | 16.8% | 22.3 | -7.45% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
11.1B | 41.8% | - | 65.1% | 320 | 58.7% |
| JAZZ Jazz |
Pharmaceuticals
Xywav, Xyrem, Epidiolex, Rylaze |
10.3B | 51.2% | - | 45.4% | - | 17.3% |
| CORT Corcept |
Pharmaceuticals
Hyperglycemia, Cushings |
8.71B | 65.7% | - | -9.21% | 95.0 | -41.3% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Wake-Promoting |
7.75B | 32.3% | - | 67.4% | - | 83.4% |
| TERN Terns |
Pharmaceuticals
Kinase Inhibitor, Thyroid Agonist |
4.61B | 34.7% | - | 63.0% | - | 519% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
4.05B | 60.9% | - | 71.9% | - | 35.1% |
| TARS Tarsus |
Pharmaceuticals
Eye Therapy, Mite Blepharitis |
3.50B | 36.6% | - | 59.5% | - | 25.6% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.47B | 85.5% | 57.1% | 38.0% | 22.2 | -3.62% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, GalNAc-Conjugated |
3.39B | 36.4% | - | 33.9% | - | 16.7% |
| LQDA Liquidia |
Pharmaceuticals
Dry Powder Injectable Liposomal |
3.11B | 27.4% | - | 73.6% | - | 149% |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic, Diaper, Throat, Eye |
3.09B | 63.6% | 0.21% | -42.6% | 15.6 | -32.9% |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.97B | 45.8% | - | 65.6% | - | 16.8% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dexamethasone, Axitinib, Travoprost |
2.71B | 32.2% | - | 44.9% | - | 20.8% |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.66B | 51.3% | 4.02% | -22.7% | 7.40 | -26.8% |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, BP1.15205 |
2.17B | 91.9% | - | 10.7% | 11.9 | -7.62% |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.13B | 73.4% | 28.6% | 8.08% | 16.9 | -17.4% |
| AVDL Avadel |
Pharmaceuticals
Sodium Oxybate, Narcolepsy |
2.12B | 64.0% | - | 57.9% | - | 74.2% |
| MAZE Maze Therapeutics |
Pharmaceuticals
MZE829, MZE782, MZE001, Renal |
2.02B | 24.8% | - | 90.6% | - | 127% |
| PRGO Perrigo |
Pharmaceuticals
OTC, Vitamins, Infant Formula |
1.89B | 46.5% | 72.3% | -65.4% | - | -51.4% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
1.87B | 56.7% | 50.9% | -62.0% | 3.76 | -58.1% |
| HROW Harrow Health |
Pharmaceuticals
Antibiotic, Steroid |
1.86B | 43.9% | - | 66.5% | - | 24.1% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
1.85B | 68.5% | - | 46.3% | 51.4 | 21.3% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Chronic Cough, Nalbuphine |
1.66B | 37.4% | - | 69.1% | - | 158% |
| INVA Innoviva |
Pharmaceuticals
Inhaled Combo, Vasoconstrictor |
1.66B | 80.6% | 2.39% | 35.5% | 13.4 | -2.13% |
| COLL Collegium |
Pharmaceuticals
Stimulant, Buccal, Opioid |
1.57B | 78.8% | - | 54.5% | 30.4 | 37.3% |
| PAHC Phibro Animal |
Pharmaceuticals
Antibacterials, Vaccines |
1.55B | 61.6% | 34.4% | 55.6% | 22.9 | 53.6% |
| EYPT Eyepoint |
Pharmaceuticals
Sustained Drug Implant, VEGF |
1.51B | 29.0% | - | 77.7% | - | 108% |
| EVT Evotec SE |
Pharmaceuticals
Oncology, Autoimmune, Metabolic |
1.49B | 22.2% | - | -69.0% | - | -45.0% |
| RAPP Rapport |
Pharmaceuticals
Epilepsy, Neuropathic Pain |
1.47B | 32.2% | - | 69.4% | - | 45.3% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, AMX0035, AMX0114, GLP-1 |
1.37B | 30.2% | - | 24.1% | - | 171% |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
1.32B | 46.7% | - | 47.2% | - | 3.42% |
| PHAT Phathom |
Pharmaceuticals
Tablet, Antibiotic, Proton-Pump |
1.26B | 66.3% | - | 66.9% | - | 73.6% |
| AMPH Amphastar P |
Pharmaceuticals
Injectable, Inhalation |
1.25B | 76.4% | - | -11.1% | 11.9 | -38.7% |
| XERS Xeris |
Pharmaceuticals
Glucagon, Cortisol, Paralysis |
1.21B | 63.4% | - | 50.6% | - | 96.7% |
| PCRX Pacira BioSciences |
Pharmaceuticals
EXPAREL, ZILRETTA, Iovera |
1.19B | 62.2% | - | 9.88% | 56.4 | 16.7% |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
1.09B | 41.8% | - | 52.9% | - | 47.7% |
| CRON Cronos |
Pharmaceuticals
Dried Flower, Pre-Roll, Oil |
1.05B | 47.1% | - | 41.0% | 24.9 | 10.6% |
| TLRY Tilray |
Pharmaceuticals
Cannabis, Beverages, Wellness |
1.05B | 47.7% | - | -46.8% | - | -42.3% |
| ELVN Enliven |
Pharmaceuticals
Kinase Inhibitor, HER2 Inhibitor |
993M | 32.4% | - | -45.0% | - | -41.9% |
| CRMD CorMedix |
Pharmaceuticals
Antimicrobial, Catheter, Solution |
983M | 91.8% | - | 50.9% | 5.65 | 22.0% |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Norepinephrine |
949M | 51.0% | - | 83.7% | 32.9 | 68.9% |
| ARVN Arvinas |
Pharmaceuticals
Protac, Degrader, Breast |
893M | 39.9% | - | -2.82% | - | -47.5% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Autoimmune, Inflammation, Cancer |
869M | 32.5% | - | 50.0% | - | 157% |
| NBY NovaBay |
Pharmaceuticals
Wound Cleanser, Hypochlorous Acid |
781M | 51.5% | 30.2% | 31.7% | 1.20 | 1,108% |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
778M | 23.1% | - | 51.7% | - | 104% |
| AQST Aquestive |
Pharmaceuticals
Epinephrine Film, Apomorphine |
716M | 59.2% | - | 64.9% | - | 54.1% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735 |
647M | 35.3% | - | 59.6% | - | 250% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Antidepressant, Cognitive |
573M | 44.2% | - | 55.4% | - | 257% |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
505M | 46.6% | - | 64.0% | 1.03 | 94.1% |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
483M | 17.5% | - | -51.2% | - | -64.7% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
463M | 30.5% | - | -21.4% | - | -33.7% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Alcohol, Retail, Flower |
458M | 50.9% | - | -47.3% | - | -21.2% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox Treatment |
449M | 79.6% | 88.7% | 12.5% | 6.09 | -4.63% |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
444M | 28.9% | - | -52.7% | - | -48.8% |
| ETON Eton |
Pharmaceuticals
Growth Hormone Deficiency, enal |
444M | 57.1% | - | 33.1% | - | 7.84% |
| RLMD Relmada |
Pharmaceuticals
Gemcitabine, Docetaxel |
331M | 45.2% | - | 85.7% | - | 689% |
| ACRS Aclaris |
Pharmaceuticals
JAK Inhibitor, TSLP Antibody |
329M | 32.8% | - | 5.11% | - | 3.10% |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Small-Molecule |
308M | 25.5% | - | -15.7% | - | -18.9% |
| NMRA Neumora |
Pharmaceuticals
Kappa Antagonist, Agitation Drug |
302M | 49.5% | - | -31.5% | - | -85.7% |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
283M | 30.4% | - | 6.32% | - | -9.47% |
| ACB Aurora Cannabis |
Pharmaceuticals
Cannabis, Oils, Capsules, Edibles |
259M | 67.1% | - | -45.1% | - | -15.7% |
| MDWD Mediwound |
Pharmaceuticals
Burn Debridement, Chronic Wound |
241M | 20.3% | - | 15.8% | - | -11.9% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading Platform, Payment Gateway |
239M | 27.8% | 1.0% | -63.4% | - | -79.9% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis, Flower, Pre-Rolls |
229M | 20.8% | - | 0.09% | - | -11.4% |
| MIST Milestone |
Pharmaceuticals
Etripamil, Calcium Channel |
166M | 24.5% | - | -12.2% | - | -27.3% |
| SAVA Cassava Sciences |
Pharmaceuticals
Simufilam, SavaDx |
142M | 34.6% | 0.17% | -48.1% | - | -28.7% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Vaccine, Lymph Node, Preclinical |
139M | 45.7% | - | -2.94% | - | 32.6% |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Diseases |
139M | 40.0% | - | 28.2% | - | 43.5% |
| VRCA Verrica |
Pharmaceuticals
Cantharidin, VP-102, VP-315 |
133M | 26.1% | - | 19.4% | - | 0.84% |
| CNTX Context |
Pharmaceuticals
Anti-Claudin6 Bispecific, T-Cell |
106M | 29.8% | - | 52.3% | - | 18.9% |
| SLGL Sol Gel |
Pharmaceuticals
Acne Cream, Rosacea Cream |
99.1M | 28.6% | - | 36.3% | - | 285% |
| SCLX Scilex Holding |
Pharmaceuticals
Lidocaine, Migraine, Anti-Gout |
96.2M | 67.5% | - | -47.3% | - | -30.5% |
| EVOK Evoke Pharma |
Pharmaceuticals
Nasal Spray, Diabetic Gastroparesis |
19.0M | 30.9% | - | 49.2% | - | 327% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual Tablets, Aspirin |
13.4M | 39.1% | - | -70.4% | - | -99.0% |
| KALA Kala |
Pharmaceuticals
KPI-012, KPI-014, Eye Therapy |
6.97M | 25.4% | - | -67.5% | - | -93.2% |
| YCBD cbdMD |
Pharmaceuticals
CBD Tinctures, Gummies, Topicals |
6.58M | 15.4% | - | -29.9% | 1.45 | -61.8% |